Flags of India and Israel (Photos: Pexels)
India’s Sun Pharma and Israel’s Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis. The studies, featured in the peer-reviewed Osteoarthritis and Cartilage journal, show that a single injection of MM-II can provide long-lasting pain relief and protect cartilage.
The drug, developed in Israel and supported by Sun Pharma, recently received Fast Track Designation from the US FDA. New findings will be presented at the OARSI 2025 World Congress.
Noting that the recent conclusion of the India-UK FTA and the Double Contribution Convention is…
Highlighting the significance of strengthening early warning systems to mitigate risks from disasters, Prime Minister…
The Central government has raised financial limits under the General Financial Rules (GFRs) for procurement…
Former Member of Parliament of Canada, Chandra Arya, has said it would be his pleasure…
UK Foreign Secretary David Lammy will meet with Prime Minister Narendra Modi on his second…
Gujarat Health Minister Rushikesh Patel on Saturday noted that the state is fully prepared for…
